Piper Sandler reiterated coverage on SeaSpine with a new price target
$SPNE
Medical Specialities
Health Care
Piper Sandler reiterated coverage of SeaSpine with a rating of Overweight and set a new price target of $22.00 from $18.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/2/2022 | $12.00 → $6.75 | Buy → Hold | Truist |
| 4/22/2022 | $27.00 → $21.00 | Overweight | Cantor Fitzgerald |
| 4/13/2022 | $20.00 | Buy | Truist |
| 12/21/2021 | $25.00 → $20.00 | Buy | Truist Securities |
| 10/28/2021 | $100.00 | Buy | Loop Capital |